This pentadecapeptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) demonstrates remarkable physicochemical stability across diverse biological environments, including resistance to gastric acid degradation and enzymatic hydrolysis, which facilitates multiple routes of administration including enteral delivery
PubMed Buckley, S.T., Bkdal, T.A., Vegge, A., Maarbjerg, S.J., Pyke, C., Ahnfelt-Rnne, J., Madsen, K.G., Schele, S.G., Alanentalo, T., Kirk, R.K., Pedersen, B.L., Skyggebjerg, R.B., Benie, A.J., Strauss, H.M., Wahlund, P.O., Bjerregaard, S., Farkas, E., Fekete, C., Sndergaard, F.L., Borregaard, J., Hartoft-Nielsen, M.L., & Knudsen, L.B
Cytokines in atherosclerosis: pathogenic and regulatory pathways
Contraindications Do not use DSIP if you: Are pregnant or breastfeeding (insufficient safety data) Have sleep apnea or other breathing-related sleep disorders (sedation risk) Take prescription sedatives or sleep medications Have a history of severe reactions to injected peptides Are under 18 years old If you have any chronic medical condition or take regular medications, consult a healthcare provider familiar with peptide therapies before starting DSIP
However, enhanced expression of GGT and MRP1, which are associated with the -glutamyl cycle, has been observed in damaged myocardium [33, 34, 51, 52]
XW: Investigation, Methodology, Writing original draft